From the aUnit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
bStatistics and Data Analysis, Danish Cancer Society Research Center, Copenhagen, Denmark
cSteno Diabetes Center Copenhagen, Copenhagen, Denmark
dUniversity of Southern Denmark, Odense, Denmark
eDepartment of Gynecology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Submitted October 21, 2020; accepted May 12, 2021
S.K.K. has received lectures fees from Merck and a research grant through her institution from Merck. M.E.J. has received research grants from Astra Zeneca, Sanofi Aventis, AMGEN, Boehringer Ingelheim and holds shares in Novo Nordisk A/S. B.C. holds shares in Novo Nordisk A/S and has received lecture and consultancy fees from Novo Nordisk and Leo Pharma. All other authors declare no potential conflicts of interest.
Individual participant data for this study are not available for data sharing. The study protocol, including data management plan and statistical analysis plan, is available on request.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Correspondence: Susanne Krüger Kjær, Unit of Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. E-mail: [email protected].